Palisade Bio, Inc.
Status: Publicly traded
Direct answer
Palisade Bio, Inc. is publicly traded on NASDAQ under the ticker PALI.
Palisade Bio, Inc. is a clinical-stage biopharmaceutical firm dedicated to identifying, advancing, and bringing to market orally administered treatments for significant conditions stemming from a compromised gastrointestinal mucosal barrier. The company's primary therapeutic candidate, LB1148, is an oral liquid formulation designed to inhibit digestive enzymes. Its goal is to safeguard gut integrity when the...
Can you invest in Palisade Bio, Inc.?
Yes. Palisade Bio, Inc. trades publicly on NASDAQ as PALI.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Palisade Bio, Inc.
Detailed equity research is provided by MarketSnap.